Goldman Sachs’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-196,125
| Closed | -$628K | – | 5100 |
|
|
2024
Q4 | $628K | Buy |
+196,125
| New | +$628K | ﹤0.01% | 4174 |
|
|
2022
Q2 | – | Sell |
-16,521
| Closed | -$292K | – | 5709 |
|
|
2022
Q1 | $292K | Buy |
+16,521
| New | +$292K | ﹤0.01% | 4897 |
|
|
2021
Q3 | – | Sell |
-13,009
| Closed | -$384K | – | 5367 |
|
|
2021
Q2 | $384K | Buy |
13,009
+10,529
| +425% | +$311K | ﹤0.01% | 4567 |
|
|
2021
Q1 | $78K | Sell |
2,480
-4,171
| -63% | -$131K | ﹤0.01% | 5079 |
|
|
2020
Q4 | $176K | Buy |
6,651
+4,273
| +180% | +$113K | ﹤0.01% | 4308 |
|
|
2020
Q3 | $64K | Buy |
+2,378
| New | +$64K | ﹤0.01% | 4290 |
|
|
2020
Q2 | – | Sell |
-2,288
| Closed | -$35K | – | 4384 |
|
|
2020
Q1 | $35K | Buy |
+2,288
| New | +$35K | ﹤0.01% | 4309 |
|
|
2018
Q2 | – | Sell |
-2,145
| Closed | -$94K | – | 4182 |
|
|
2018
Q1 | $94K | Buy |
+2,145
| New | +$94K | ﹤0.01% | 4026 |
|